Clinical Trials Browser

Phase 3 × Lung Neoplasms × Darbepoetin alfa × Clear all

NCT03776032 2018-12-20

A Novel Erythropoiesis Stimulating Protein (NESP; Darbopoetin Alfa) for the Treatment of Anemia in Lung Cancer Patients Receiving Multi-cycle Platinum-Containing Chemotherapy

Phase 3 Completed

Classical hematologyThoracic

Anemia, Lung Neoplasms